ERS 2022: Video met Dr. Maarten van den Berge, UMCG Groningen
September 2022
astma
ERS 2022
tozorakimab
van den Berge
OA2254: Tozorakimab: a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
Sessie: Clinical and translational studies of asthma and COPD: novel mechanisms
Wilt u meer lezen? Log dan in.
Gerelateerde items
